GMP certification bodes well for Alexza’s lead product

August 28, 2012
Manufacturing and Production Alexza, FDA, GMP, schizophrenia

US drugmaker Alexza Pharmaceuticals’ manufacturing facility for lead product Adasuve has been given a green light from the Spanish medicine …

EMA warns of sterility issues with DepoCyte

August 28, 2012
Manufacturing and Production DepoCyte, Depocyt, Pacira, pharma recalls

The European Medicines Agency has issued a warning to US drugmaker Pacira Pharmaceuticals over manufacturing deficiencies at the plant making …

Pharma manufacturing news in brief

August 28, 2012
Manufacturing and Production Agennix, Bilcare, United Drug, West Pharmaceutical Services B. Braun Group

Agennix trial failure affects Lonza and DSM, United Drug buys Bilcare ops, plus facility news from West Pharma and B. …

Bosch gets bigger in India; unveils new capsule filler

August 28, 2012
Manufacturing and Production Bosch, India

Bosch Packaging Technology has expanded its presence in India with the opening of a new facility in Goa to help …

Ethical dilemmas add to ‘critical weaknesses’ In FDA safety monitoring

August 25, 2012
Sales and Marketing Avandia, Post-marketing surveillance, pharmacovigilance

Ethical challenges are central to continuing “critical weaknesses” in the FDA’s drug safety monitoring, according to a commentary by former …

lilly_corporate_hq

Lilly’s Alzheimer’s drug fails in phase III

August 24, 2012
Sales and Marketing Alzheimer's, EXPEDITION, lilly, solanezumab

 Lilly has announced that its Alzheimer’s drug candidate solanezumab has failed its primary endpoints in two key phase III trials. …

Indian reps strike over pharma’s bad ethics

August 24, 2012
Sales and Marketing FMRAI, India, pharma, reps

Pharma reps in India have gone on strike to highlight what they see as the corrupt nature of the pharma …

NHS must tackle ‘tsunami of bureaucracy’

August 24, 2012
Sales and Marketing CCGs, Farrar, NHS, reforms

The NHS Confederation has expressed concerns that the government’s reform of the health service will lead to a ‘tsunami of …

Pfizer image

Pfizer and Mylan sign Japanese generics deal

August 23, 2012
Sales and Marketing Mylan, Pfizer, generics

Pfizer and Mylan have struck a deal to sell generic drugs together in Japan, the world’s second biggest pharma market. …

Novartis image

Novartis’ Indian patent case delayed

August 23, 2012
Sales and Marketing Glivec, MSF, Novartis, generics

Novartis’ court case against the Indian government has been put on hold until next month. The case was suppose to …

Syrum image

Boehringer’s Syrum Facebook game launch date released

August 22, 2012
Medical Communications Boehringer, Facebook, Syrum

Boehringer Ingelheim has announced the launch date of its social media game Syrum. John Pugh, Boehringer’s director of digital communications …

Allergan signs $1.5 billion deal with Molecular Partners

August 22, 2012
Research and Development, Sales and Marketing Allergan, Molecular Partners, eye diseases

Allergan has signed a deal potentially worth $1.5 billion with Molecular Partners to develop new drugs for certain eye diseases. …

NHS image

UK government pushes through formulary changes

August 22, 2012
Sales and Marketing CCGs, NHS, NICE, PCTs, UK, lottery, prescribing

The government has written to NHS prescribing leads telling them they must start to incorporate NICE guidance into their formularies. …

Doctor and computer image

UK doctors not going digital for product information

August 22, 2012
Medical Communications GPs, UK, digital, doctorsnet

A new survey has revealed that the majority of doctors in the UK are not looking online for information about …

screen_shot_2012-08-22_at_09

Lundbeck makes two senior appointments

August 22, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andreas Eggert, Klaus Abel, Lundbeck

Lundbeck has appointed Andreas Eggert (pictured) as senior vice president for global product strategy, and Klaus Abel as vice president …

Avastin image

Another NICE no for Avastin in breast cancer

August 22, 2012
Sales and Marketing NICE, avastin, breast cancer, rejection

Roche’s Avastin has been rejected once again for use in breast cancer patients.  NICE has now issued final guidance saying …

Pfizer’s arthritis drug delayed by FDA

August 21, 2012
Research and Development, Sales and Marketing FDA, Pfizer, tofacitinib

Pfizer says its new rheumatoid arthritis drug tofacitinib has been delayed by the FDA. Tofacitinib, an oral Janus kinase (JAK) …

Charity launches ‘Diabetes App Challenge’

August 21, 2012
Medical Communications apps, diabetes, digital

Diabetes UK has launched its Diabetes App Challenge for younger insulin dependent patients. The Diabetes App Challenge wants people with …

Whitehead image

NICE bows to industry pressure

August 21, 2012
Sales and Marketing ABPI, NICE, QALY, VBP

NICE has bowed to industry pressure and will allow independent advisors to sit on its appeals board. An appeal can …

screen_shot_2012-08-21_at_09

INC Research promotes Jamie Macdonald to chief executive

August 21, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing INC Research, Jamie Macdonald

Clinical research organisation INC Research has announced chief operating officer Jamie Macdonald will become the firm’s next president and chief …

The Gateway to Local Adoption Series

Latest content